Skip to product information
CJC-1295 DAC lyophilized research peptide vial laboratory grade

CJC-1295 With Dac 2MG

£18.99
Taxes included.

CJC-1295 with DAC Peptide – Research Grade Growth Hormone Releasing Hormone Analog

 

CJC-1295 with DAC is a synthetic peptide analog of growth hormone releasing hormone (GHRH) developed for laboratory research. The peptide incorporates a Drug Affinity Complex (DAC) which extends its half-life in research models, allowing for prolonged interaction with growth hormone releasing pathways.

 

In scientific research settings, CJC-1295 with DAC has been investigated for its potential influence on growth hormone signaling pathways, insulin-like growth factor (IGF-1) regulation, and endocrine system mechanisms. The extended activity provided by the DAC modification allows researchers to study long-acting GHRH analog behavior in controlled experimental environments.

 

Because of these characteristics, CJC-1295 with DAC has become a widely studied peptide in laboratory research exploring hormone signaling pathways and metabolic regulatory mechanisms.

 

Our CJC-1295 with DAC peptide is supplied as a high-purity lyophilised powder, manufactured under controlled laboratory conditions to ensure consistency, stability, and purity for scientific research applications.

 

Each vial contains 2mg of research-grade CJC-1295 with DAC peptide, sealed in a sterile glass vial to preserve peptide integrity. Lyophilisation helps maintain peptide stability during storage and transportation.

 

This compound is intended strictly for laboratory research purposes only and is not approved for human or veterinary use.

Research Highlights

  • Studied as a growth hormone releasing hormone (GHRH) analog
  • Investigated for potential effects on growth hormone signaling pathways
  • Research exploring interactions with insulin-like growth factor-1 (IGF-1)
  • Studied for its extended half-life due to Drug Affinity Complex (DAC) modification
  • Investigated in experimental models related to endocrine and metabolic regulation

peptide overview

CJC-1295 with DAC is a synthetic peptide analog of growth hormone releasing hormone (GHRH). The peptide was developed to extend the biological activity of GHRH through the addition of a Drug Affinity Complex (DAC), which allows the compound to bind to circulating albumin and remain active for longer periods in research environments.

In laboratory research, CJC-1295 with DAC has been investigated for its potential interaction with growth hormone release pathways and endocrine regulatory systems. The extended half-life provided by the DAC modification allows researchers to study sustained signaling effects in experimental models.

Because of its long-acting properties, CJC-1295 with DAC has become a widely studied compound in growth hormone and metabolic pathway research.

Molecular information

  • Peptide Name: CJC-1295 with DAC
  • Peptide Type: Growth Hormone Releasing Hormone (GHRH) Analog
  • Molecular Formula: C152H252N44O42
  • Molecular Weight: 3647.2 g/mol
  • CAS Number: 863288-34-0

Product specification

  • Purity: ≥99% (HPLC tested)
  • Quantity: 2mg per vial
  • Form: Lyophilised powder
  • Grade: Research grade
  • Appearance: White lyophilised powder

Storage Instructions

  •  Store at 2–8°C
  • Protect from light exposure
  • Avoid repeated freeze-thaw cycles

reconstitution

CJC-1295 peptides are typically reconstituted using bacteriostatic water prior to laboratory research use.

Researchers should follow appropriate peptide handling procedures when preparing solutions.

Check out our Peptide Calculator for easy mixing.

Disclaimer

This product is intended strictly for laboratory research purposes only.


It is not intended for human consumption, medical use, veterinary use, or household use.

Goes well with...